Anika Therapeutics Inc
For the period ended Dec 31, 2023. Filed Mar 15, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 15, 2024
ANIK$13.81-1.0%Stored close · as of Nov 12, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Part IV
Checking your notes…
**ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.